树突细胞在反应性瘤免疫的中心
Lomax Pass1,2, Matthew F Krummel1,2
1Department of Pathology, University of California, San Francisco, San Francisco, California, USA.
Immunological reviews
|November 17, 2025
概括
瘤消除依赖于T细胞,而树突细胞 (DCs) 是至关重要的. 了解DC异质性和相互作用可以促进免疫疗法和抗瘤疫苗的开发.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 瘤的消除依赖于T细胞,需要激活信号.
- 树突细胞 (DCs) 是瘤反应性免疫和免疫治疗成功的关键参与者.
- 最近的研究强调了DC异质性及其与瘤内的其他细胞的相互作用.
研究的目的:
- 审查当前对内树突细胞生物学的理解.
- 在癌症免疫的背景下讨论树突细胞研究的最新进展.
- 探索通过DC增强抗瘤免疫反应的未来方向.
主要方法:
- 最近科学出版物的文献综述.
- 关于树突细胞异质性和功能发现的综合.
- 对影响抗瘤免疫力的细胞相互作用的分析.
主要成果:
- 树突细胞在瘤中表现出显著的异质性,具有专门的作用.
- 一个复杂的细胞相互作用网络影响DC功能和抗瘤免疫力.
- 了解这些动态使新的治疗策略成为可能.
结论:
- 了解内DC生物学方面的进展对于癌症免疫治疗至关重要.
- 工程树突细胞疫苗和其他方法可以产生新的抗瘤免疫力.
- 未来的研究应该专注于利用直流网络来改善癌症治疗.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Cell-mediated Immune Responses
83.4K
Overview
83.4K
Antigen Presenting Cells
2.9K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
2.9K


